Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Lennox–Gastaut syndrome (LGS) is a complex, rare, and severe childhood-onset epilepsy. It is characterized by multiple and concurrent seizure types, cognitive dysfunction, and slow spike waves on electroencephalogram (EEG). Typically, it presents in children aged 3–5 years and can persist into adulthood.
Corpus callosotomy is a surgical procedure used for treating refractory generalized seizures caused due to Lennox-Gastaut syndrome (LGS). However, this surgical procedure involves craniotomy with microdissection. Therefore, companies are focusing on the development of minimally invasive procedures such as MR-guided laser interstitial thermal therapy (MRg-LITT). MRg-LITT has emerged as a safe, effective, and durable alternative of traditional open corpus callosotomy. The efficacy of MRg-LITT is also being tested in advanced surgical ablation of epileptogenic foci and corpus callosotomy. This will further boost its adoption in LGS treatment. Such advancements in surgical treatments will be one of the key trends that will impact LGS market growth in the coming years.
This report offers an overview of the market trends, drivers, and barriers with respect to the USA Lennox-Gastaut Syndrome Treatment market. It also provides a detailed overview of the market of different regions across West USA, South USA, Middle West USA, Northeast USA. The report deeply analyzes type and application in the USA Lennox-Gastaut Syndrome Treatment market. Detailed analysis of key players, along with key growth strategies adopted by Lennox-Gastaut Syndrome Treatment industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.
By Player:
Johnson & Johnson Services, Inc
Eisai Co, Ltd
H Lundbeck A/S
GlaxoSmithKline plc
Supernus Pharmaceuticals, Inc
By Type:
Non-surgical Treatment
Surgical Treatment
By End-User:
Hospital
Clinic
Other
By Region:
-
West USA
-
South USA
-
Middle West USA
-
Northeast USA
TABLE OF CONTENT
1 Report Overview
-
1.1 Product Definition and Scope
-
1.2 PEST (Political, Economic, Social and Technological) Analysis of Lennox-Gastaut Syndrome Treatment Market
-
1.3 Market Segment by Type
-
1.3.1 USA Lennox-Gastaut Syndrome Treatment Market Size and Growth Rate of Non-surgical Treatment from 2016 to 2027
-
1.3.2 USA Lennox-Gastaut Syndrome Treatment Market Size and Growth Rate of Surgical Treatment from 2016 to 2027
-
1.4 Market Segment by Application
-
1.4.1 USA Lennox-Gastaut Syndrome Treatment Market Size and Growth Rate of Hospital from 2016 to 2027
-
1.4.2 USA Lennox-Gastaut Syndrome Treatment Market Size and Growth Rate of Clinic from 2016 to 2027
-
1.4.3 USA Lennox-Gastaut Syndrome Treatment Market Size and Growth Rate of Other from 2016 to 2027
-
1.5 Market Segment by Regions
-
1.5.1 West USA Lennox-Gastaut Syndrome Treatment Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.2 South USA Lennox-Gastaut Syndrome Treatment Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.3 Middle West USA Lennox-Gastaut Syndrome Treatment Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.4 Northeast USA Lennox-Gastaut Syndrome Treatment Consumption Market Size and Growth Rate from 2016 to 2027
2 Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Market Challenges and Restraints
-
2.1.2 Market Opportunities and Potentials
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape Analysis
-
2.2.1 Industrial Concentration Analysis
-
2.2.2 Porter's Five Forces Analysis of the Industry
-
2.2.3 SWOT Analysis for New Entrants
-
2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry
3 Segmentation of Lennox-Gastaut Syndrome Treatment Market by Types
-
3.1 Products Development Trends of Different Types
-
3.2 Products Types of Major Vendors
-
3.3 Competitive Landscape Analysis of Different Types
-
3.4 Market Size of Lennox-Gastaut Syndrome Treatment by Major Types
-
3.4.1 Market Size and Growth Rate of Non-surgical Treatment
-
3.4.2 Market Size and Growth Rate of Surgical Treatment
4 Segmentation of Lennox-Gastaut Syndrome Treatment Market by End-Users
-
4.1 Downstream Client Analysis by End-Users
-
4.2 Competitive Landscape Analysis of Different End-Users
-
4.3 Market Potential Analysis of Different End-Users
-
4.4 Market Size of Lennox-Gastaut Syndrome Treatment by Major End-Users
-
4.4.1 Market Size and Growth Rate of Lennox-Gastaut Syndrome Treatment in Hospital
-
4.4.2 Market Size and Growth Rate of Lennox-Gastaut Syndrome Treatment in Clinic
-
4.4.3 Market Size and Growth Rate of Lennox-Gastaut Syndrome Treatment in Other
5 Market Analysis by Regions
-
5.1 USA Lennox-Gastaut Syndrome Treatment Production Analysis by Regions
-
5.2 USA Lennox-Gastaut Syndrome Treatment Consumption Analysis by Regions
-
5.3 Coronavirus (COVID-19) Impact on USA Economy
6 West USA Lennox-Gastaut Syndrome Treatment Landscape Analysis
-
6.1 West USA Lennox-Gastaut Syndrome Treatment Landscape Analysis by Major Types
-
6.2 West USA Lennox-Gastaut Syndrome Treatment Landscape Analysis by Major End-Users
7 South USA Lennox-Gastaut Syndrome Treatment Landscape Analysis
-
7.1 South USA Lennox-Gastaut Syndrome Treatment Landscape Analysis by Major Types
-
7.2 South USA Lennox-Gastaut Syndrome Treatment Landscape Analysis by Major End-Users
8 Middle West USA Lennox-Gastaut Syndrome Treatment Landscape Analysis
-
8.1 Middle West USA Lennox-Gastaut Syndrome Treatment Landscape Analysis by Major Types
-
8.2 Middle West USA Lennox-Gastaut Syndrome Treatment Landscape Analysis by Major End-Users
9 Northeast USA Lennox-Gastaut Syndrome Treatment Landscape Analysis
-
9.1 Northeast USA Lennox-Gastaut Syndrome Treatment Landscape Analysis by Major Types
-
9.2 Northeast USA Lennox-Gastaut Syndrome Treatment Landscape Analysis by Major End-Users
10 Major Players Profiles
-
10.1 Johnson & Johnson Services, Inc
-
10.1.1 Johnson & Johnson Services, Inc Company Profile and Recent Development
-
10.1.2 Market Performance
-
10.1.3 Product and Service Introduction
-
10.2 Eisai Co, Ltd
-
10.2.1 Eisai Co, Ltd Company Profile and Recent Development
-
10.2.2 Market Performance
-
10.2.3 Product and Service Introduction
-
10.3 H Lundbeck A/S
-
10.3.1 H Lundbeck A/S Company Profile and Recent Development
-
10.3.2 Market Performance
-
10.3.3 Product and Service Introduction
-
10.4 GlaxoSmithKline plc
-
10.4.1 GlaxoSmithKline plc Company Profile and Recent Development
-
10.4.2 Market Performance
-
10.4.3 Product and Service Introduction
-
10.5 Supernus Pharmaceuticals, Inc
-
10.5.1 Supernus Pharmaceuticals, Inc Company Profile and Recent Development
-
10.5.2 Market Performance
-
10.5.3 Product and Service Introduction
The List of Tables and Figures
-
Figure Product Picture
-
Figure USA Lennox-Gastaut Syndrome Treatment Market Size and Growth Rate of Non-surgical Treatment from 2016 to 2027
-
Figure USA Lennox-Gastaut Syndrome Treatment Market Size and Growth Rate of Surgical Treatment from 2016 to 2027
-
Figure Market Share by Type in 2016
-
Figure Market Share by Type in 2020
-
Figure Market Share by Type in 2027
-
Figure USA Lennox-Gastaut Syndrome Treatment Market Size and Growth Rate of Hospital from 2016 to 2027
-
Figure USA Lennox-Gastaut Syndrome Treatment Market Size and Growth Rate of Clinic from 2016 to 2027
-
Figure USA Lennox-Gastaut Syndrome Treatment Market Size and Growth Rate of Other from 2016 to 2027
-
Figure Market Share by End-User in 2016
-
Figure Market Share by End-User in 2020
-
Figure Market Share by End-User in 2027
-
Figure West USA Lennox-Gastaut Syndrome Treatment Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure South USA Lennox-Gastaut Syndrome Treatment Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Middle West USA Lennox-Gastaut Syndrome Treatment Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northeast USA Lennox-Gastaut Syndrome Treatment Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Development Trends and Industry Dynamics of Lennox-Gastaut Syndrome Treatment Industry
-
Figure Market Challenges and Restraints
-
Figure Market Opportunities and Potentials
-
Table Mergers and Acquisition
-
Figure Market Share of TOP 3 Players in 2019
-
Figure Market Share of TOP 5 Players in 2019
-
Figure Market Share of TOP 6 Players from 2016 to 2020
-
Figure Porter's Five Forces Analysis
-
Figure New Entrant SWOT Analysis
-
Figure Coronavirus (COVID-19) Distribution Map of USA
-
Table Coronavirus (COVID-19) Impact on the Industry
-
Figure Specifications of Different Types of Lennox-Gastaut Syndrome Treatment
-
Figure Development Trends of Different Types
-
Table Products Types of Major Vendors
-
Figure Competitive Landscape Analysis of Different Types
-
Table Consumption of Lennox-Gastaut Syndrome Treatment by Different Types from 2016 to 2027
-
Table Consumption Share of Lennox-Gastaut Syndrome Treatment by Different Types from 2016 to 2027
-
Figure Market Size and Growth Rate of Non-surgical Treatment
-
Figure Market Size and Growth Rate of Surgical Treatment
-
Table Downstream Client Analysis by End-Users
-
Figure Competitive Landscape Analysis of Different End-Users
-
Table Market Potential Analysis of Different End-Users
-
Figure Consumption of Lennox-Gastaut Syndrome Treatment by Different End-Users from 2016 to 2027
-
Table Consumption Share of Lennox-Gastaut Syndrome Treatment by Different End-Users from 2016 to 2027
-
Figure Market Size and Growth Rate of Hospital
-
Figure Market Size and Growth Rate of Clinic
-
Figure Market Size and Growth Rate of Other
-
Table USA Lennox-Gastaut Syndrome Treatment Production by Regions
-
Table USA Lennox-Gastaut Syndrome Treatment Production Share by Regions
-
Figure USA Lennox-Gastaut Syndrome Treatment Production Share by Regions in 2016
-
Figure USA Lennox-Gastaut Syndrome Treatment Production Share by Regions in 2021
-
Figure USA Lennox-Gastaut Syndrome Treatment Production Share by Regions in 2027
-
Table USA Lennox-Gastaut Syndrome Treatment Consumption by Regions
-
Table USA Lennox-Gastaut Syndrome Treatment Consumption Share by Regions
-
Figure USA Lennox-Gastaut Syndrome Treatment Consumption Share by Regions in 2016
-
Figure USA Lennox-Gastaut Syndrome Treatment Consumption Share by Regions in 2021
-
Figure USA Lennox-Gastaut Syndrome Treatment Consumption Share by Regions in 2027
-
Table West USA Lennox-Gastaut Syndrome Treatment Consumption by Types from 2016 to 2027
-
Table West USA Lennox-Gastaut Syndrome Treatment Consumption Share by Types from 2016 to 2027
-
Figure West USA Lennox-Gastaut Syndrome Treatment Consumption Share by Types in 2016
-
Figure West USA Lennox-Gastaut Syndrome Treatment Consumption Share by Types in 2021
-
Figure West USA Lennox-Gastaut Syndrome Treatment Consumption Share by Types in 2027
-
Table West USA Lennox-Gastaut Syndrome Treatment Consumption by End-Users from 2016 to 2027
-
Table West USA Lennox-Gastaut Syndrome Treatment Consumption Share by End-Users from 2016 to 2027
-
Figure West USA Lennox-Gastaut Syndrome Treatment Consumption Share by End-Users in 2016
-
Figure West USA Lennox-Gastaut Syndrome Treatment Consumption Share by End-Users in 2021
-
Figure West USA Lennox-Gastaut Syndrome Treatment Consumption Share by End-Users in 2027
-
Table South USA Lennox-Gastaut Syndrome Treatment Consumption by Types from 2016 to 2027
-
Table South USA Lennox-Gastaut Syndrome Treatment Consumption Share by Types from 2016 to 2027
-
Figure South USA Lennox-Gastaut Syndrome Treatment Consumption Share by Types in 2016
-
Figure South USA Lennox-Gastaut Syndrome Treatment Consumption Share by Types in 2021
-
Figure South USA Lennox-Gastaut Syndrome Treatment Consumption Share by Types in 2027
-
Table South USA Lennox-Gastaut Syndrome Treatment Consumption by End-Users from 2016 to 2027
-
Table South USA Lennox-Gastaut Syndrome Treatment Consumption Share by End-Users from 2016 to 2027
-
Figure South USA Lennox-Gastaut Syndrome Treatment Consumption Share by End-Users in 2016
-
Figure South USA Lennox-Gastaut Syndrome Treatment Consumption Share by End-Users in 2021
-
Figure South USA Lennox-Gastaut Syndrome Treatment Consumption Share by End-Users in 2027
-
Table Middle West USA Lennox-Gastaut Syndrome Treatment Consumption by Types from 2016 to 2027
-
Table Middle West USA Lennox-Gastaut Syndrome Treatment Consumption Share by Types from 2016 to 2027
-
Figure Middle West USA Lennox-Gastaut Syndrome Treatment Consumption Share by Types in 2016
-
Figure Middle West USA Lennox-Gastaut Syndrome Treatment Consumption Share by Types in 2021
-
Figure Middle West USA Lennox-Gastaut Syndrome Treatment Consumption Share by Types in 2027
-
Table Middle West USA Lennox-Gastaut Syndrome Treatment Consumption by End-Users from 2016 to 2027
-
Table Middle West USA Lennox-Gastaut Syndrome Treatment Consumption Share by End-Users from 2016 to 2027
-
Figure Middle West USA Lennox-Gastaut Syndrome Treatment Consumption Share by End-Users in 2016
-
Figure Middle West USA Lennox-Gastaut Syndrome Treatment Consumption Share by End-Users in 2021
-
Figure Middle West USA Lennox-Gastaut Syndrome Treatment Consumption Share by End-Users in 2027
-
Table Northeast USA Lennox-Gastaut Syndrome Treatment Consumption by Types from 2016 to 2027
-
Table Northeast USA Lennox-Gastaut Syndrome Treatment Consumption Share by Types from 2016 to 2027
-
Figure Northeast USA Lennox-Gastaut Syndrome Treatment Consumption Share by Types in 2016
-
Figure Northeast USA Lennox-Gastaut Syndrome Treatment Consumption Share by Types in 2021
-
Figure Northeast USA Lennox-Gastaut Syndrome Treatment Consumption Share by Types in 2027
-
Table Northeast USA Lennox-Gastaut Syndrome Treatment Consumption by End-Users from 2016 to 2027
-
Table Northeast USA Lennox-Gastaut Syndrome Treatment Consumption Share by End-Users from 2016 to 2027
-
Figure Northeast USA Lennox-Gastaut Syndrome Treatment Consumption Share by End-Users in 2016
-
Figure Northeast USA Lennox-Gastaut Syndrome Treatment Consumption Share by End-Users in 2021
-
Figure Northeast USA Lennox-Gastaut Syndrome Treatment Consumption Share by End-Users in 2027
-
Table Company Profile and Development Status of Johnson & Johnson Services, Inc
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Johnson & Johnson Services, Inc
-
Figure Sales and Growth Rate Analysis of Johnson & Johnson Services, Inc
-
Figure Revenue and Market Share Analysis of Johnson & Johnson Services, Inc
-
Table Product and Service Introduction of Johnson & Johnson Services, Inc
-
Table Company Profile and Development Status of Eisai Co, Ltd
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Eisai Co, Ltd
-
Figure Sales and Growth Rate Analysis of Eisai Co, Ltd
-
Figure Revenue and Market Share Analysis of Eisai Co, Ltd
-
Table Product and Service Introduction of Eisai Co, Ltd
-
Table Company Profile and Development Status of H Lundbeck A/S
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of H Lundbeck A/S
-
Figure Sales and Growth Rate Analysis of H Lundbeck A/S
-
Figure Revenue and Market Share Analysis of H Lundbeck A/S
-
Table Product and Service Introduction of H Lundbeck A/S
-
Table Company Profile and Development Status of GlaxoSmithKline plc
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of GlaxoSmithKline plc
-
Figure Sales and Growth Rate Analysis of GlaxoSmithKline plc
-
Figure Revenue and Market Share Analysis of GlaxoSmithKline plc
-
Table Product and Service Introduction of GlaxoSmithKline plc
-
Table Company Profile and Development Status of Supernus Pharmaceuticals, Inc
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Supernus Pharmaceuticals, Inc
-
Figure Sales and Growth Rate Analysis of Supernus Pharmaceuticals, Inc
-
Figure Revenue and Market Share Analysis of Supernus Pharmaceuticals, Inc
-
Table Product and Service Introduction of Supernus Pharmaceuticals, Inc
-
